Amyris Biotechnologies tacks on $21M for biofuel development
One of the most highly valued biofuel startups in the country, Amyris Biotechnologies, has taken on an additional $21 million as part of its previously announced $70 million second round of funding, according to VentureWire.
Amyris is a synthetic biology company that is working on microorganisms to create analogs of gasoline, diesel and jet fuel. Earlier this year, it joined a venture in Brazil, Crystalsev, to make fuel from sugar in that country.
The company was valued at $470 million for the round, and has now taken $91 million as part of the funding. It also raised $20 million in 2006.
The names of the new investors were not disclosed, but the company told VentureWire that the round, originally capped at $70 million, remains open. Amyris is based in Emeryville, Calif.
Next Story: TrueBridge Capital captures $310M for fund of funds
Previous Story: Twitter joins the Olympics, as a Chinese journalist cries out for help
Tags: deal
VB Writers
East Coast Editor
Dean TakahashiLead Writer, GamesBeat
National Editor, MobileBeat Lead
Executive Editor
Editor-in-Chief, GamesBeat
Senior Editor
Writer
Writer
Founder & Editor-in-Chief
Writer
Editorial Assistant
Writer
Reviews Editor, GamesBeat
Tom CheredarWriter
Contributor
Julia PlevinContributor
Contributor









